SCHEMBL28679228

SCHEMBL28679228

CSc1ncc2c(C)c(Br)c(=O)n([C@H]3CC[C@H](N(C(=O)O)C(C)(C)C)CC3)c2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 16/20 0.39
CCND1 P24385 16/20 0.39
CCND3 P30281 13/20 0.39
CCND2 P30279 9/20 0.39
CDK2 P24941 4/20 0.38
CCNA2 P20248 3/20 0.38
CDK1 P06493 2/20 0.38
CCNE1 P24864 2/20 0.38
CCNB2 O95067 1/20 0.38
CCNE2 O96020 1/20 0.38
FGFR1 P11362 1/20 0.38
CCNB1 P14635 1/20 0.38
FGFR2 P21802 1/20 0.38
FGFR4 P22455 1/20 0.38
FGFR3 P22607 1/20 0.38
CCNA1 P78396 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38
CDK6 Q00534 5/20 0.36
PIK3CA P42336 3/20 0.35
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28382215 0.87 CDK4 (0.40) CDK4CCND1CCND3CCND2CDK2
SCHEMBL22553578 0.82 CDK4 (0.43) CDK4CCND1CCND3CCND2CDK2
SCHEMBL22553579 0.82 CDK4 (0.43) CDK4CCND1CCND3CCND2CDK2
SCHEMBL4826130 0.81 CDK4 (0.52) CDK4CCND1CCND3CCND2CDK2
SCHEMBL29507845 0.81 CDK4 (0.52) CDK4CCND1CCND3CCND2CDK2
SCHEMBL22557912 0.81 CDK4 (0.44) CDK4CCND1CCND3CCND2CDK2
SCHEMBL22553544 0.78 PIK3CA (0.43) CDK4CCND1CCND3CCND2CDK2
SCHEMBL22553522 0.77 CDK4 (0.41) CDK4CCND1CCND3CCND2CDK2
SCHEMBL22557914 0.77 CDK4 (0.41) CDK4CCND1CCND3CCND2CDK2
SCHEMBL28677140 0.75 PIK3CA (0.49) CDK4CCND1CCND3CCND2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114007697-A Antiproliferative agents for the treatment of PAH 辉瑞公司 2022-02-01 CN disclosed